Salesforce Vs. Lyra Therapeutics Industry Stock Comparison

Sell

30

CRM
Salesforce

Last Price:

$260.66

Seasonality Move:

9.77%

Sell

39

LYRA
Lyra Therapeutics

Last Price:

$10.67

Seasonality Move:

12.18%

Sell

30

Salesforce (CRM) is a Sell

Is Salesforce a Buy, Sell or Hold?

The current Salesforce [CRM] share price is $260.63. The Score for CRM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
CRM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

39

Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics a Buy, Sell or Hold?

The current Lyra Therapeutics [LYRA] share price is $10.45. The Score for LYRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRM Stock Price Chart

What is Salesforce's stock price today?

The Salesforce share price today is $260.63

The current trend is moderately bearish and CRM is experiencing slight selling pressure.

LYRA Stock Price Chart

What is Lyra Therapeutics's stock price today?

The Lyra Therapeutics share price today is $10.45

The current trend is moderately bearish and LYRA is experiencing selling pressure, which indicates risk of future bearish movement.

CRM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.37	Sell
Relative Strength Index (14 RSI):	41.71	Sell
Chaikin Money Flow:	-3099468	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(261.57 - 281.73)	Sell
Bollinger Bands (100):	(256.11 - 313.31)	Sell

LYRA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.97	Buy
Relative Strength Index (14 RSI):	47.39	Sell
Chaikin Money Flow:	-31350	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(4.11 - 18.91)	Sell
Bollinger Bands (100):	(4.01 - 12.99)	Buy

CRM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	263.28	Sell
20-day SMA:	267.57	Sell
50-day SMA:	268.61	Sell
200-day SMA:	295.53	Sell
8-day EMA:	263.11	Sell
20-day EMA:	266.64	Sell
50-day EMA:	248.26	Buy
200-day EMA:	127.07	Buy

LYRA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	11.87	Sell
20-day SMA:	13.08	Sell
50-day SMA:	8.25	Buy
200-day SMA:	9.92	Buy
8-day EMA:	12.16	Sell
20-day EMA:	12.24	Sell
50-day EMA:	10.07	Buy
200-day EMA:	22.87	Sell

Salesforce Earnings Growth & CRM Earnings Dates

Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.

Lyra Therapeutics Earnings Growth & LYRA Earnings Dates

Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

Salesforce Technical Analysis

	Jun 6	Jun 9	Jun 10	Jun 11	Jun 12	Jun 13	Jun 16	Jun 17	Jun 18	Jun 20
	Jun
	06	09	10	11	12	13	16	17	18	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyra Therapeutics Technical Analysis

	Jun 6	Jun 9	Jun 10	Jun 11	Jun 12	Jun 13	Jun 16	Jun 17	Jun 18	Jun 20
	Jun
	06	09	10	11	12	13	16	17	18	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):